MedPath

Endodontic Microsurgery With the Use of L-PRF and an Occlusive Membrane: a Randomized Controlled Clinical Trial

Not Applicable
Completed
Conditions
Periapical Periodontitis
Interventions
Procedure: EMS
Device: + occlusive membrane
Device: conebeam CT
Registration Number
NCT02528240
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
Brief Summary

This study evaluates the effect of leucocyte and platelet rich fibrin (L-PRF) during endodontic microsurgery (EMS) on patient's post-operative comfort and periapical bone healing. Also the influence of an occlusive membrane barrier in EMS on the periapical bone healing will be studied. The trial design is an open randomized controlled clinical trial with a 2x2 factorial design. Half of the participants will receive EMS with L-PRF (experimental group), the other half without (control group). The control and experimental group will be divided in 2 subsequent groups: half of the participants will receive an occlusive membrane during EMS, the other half not.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
56
Inclusion Criteria
  • Provision of Informed Consent
  • Patients in need of an EMS
  • EMS is the only option to cure the periapical lesion
Exclusion Criteria
  • Unlikely to be able to comply with the study procedures, as judged by the investigator
  • Orthograde endodontic (re)treatment is indicated
  • Known or suspected current malignancy
  • History of chemotherapy within 5 years prior to study
  • History of radiation in the head and neck region
  • History of other metabolic bone diseases
  • History of bleeding disorders
  • HIV disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
+ L-PRFconebeam CTWith leukocyte and platelet rich fibrin
- L-PRFconebeam CTWithout leukocyte and platelet rich fibrin
+ L-PRFEMSWith leukocyte and platelet rich fibrin
+ L-PRF+ occlusive membraneWith leukocyte and platelet rich fibrin
- L-PRFEMSWithout leukocyte and platelet rich fibrin
Primary Outcome Measures
NameTimeMethod
Patient related outcomes7 days

Assessed with a Visual Analog Scale

Secondary Outcome Measures
NameTimeMethod
Patient related outcomes7 days

Assessed with a questionnaire

Trial Locations

Locations (1)

UZ Leuven

🇧🇪

Leuven, Belgium

© Copyright 2025. All Rights Reserved by MedPath